Anas Al-Janadi, M.D.,
Associate Professor, Division Chief
Nikolay V. Dimitrov,
M.D., Professor Emeritus
Borys Hrinczenko, M.D., Ph.D., Associate Professor
Kenneth A. Schwartz, M.D., Professor
Deimante Tamkus, M.D.,
The Division of Hematology and Oncology specializes
in the area of cancer therapeutics, thrombosis and bleeding
disorders, and the clinical care of patients with hematologic
and oncologic disorders. Led by Dr. Anas Al-Janadi, the division
has active clinical, research, and teaching programs.
and Oncology patients are seen at the MSU Breslin Cancer
Center. This busy clinic provides care to thousands
of patients each year. Physicians also provide care
to inpatients, and consultation in their area of expertise.
Interdisciplinary cancer clinics are used to create
a care team and cancer treatment plan that involves
the patient, oncologists, radiation oncologists, surgeons,
and other experts.
Division has an active clinical trials program that
provides patients with cutting-edge treatment and helps
advance the field of oncology. The Division participates
in national cooperative groups trials, including the
National Surgical Adjuvant Breast and Bowel Project
(NSABP) and the Southwest Oncology Group, both supported
through the NIH’s National Cancer Institute. In
addition, the Clinical Trials Unit conducts many other
trials to advance the science and treatment of cancer.
MSU Division of Hematology and Oncology provides ACGME-based
training leading to Board-eligibility in both Hematology
and Oncology. The Fellowship includes scheduled didactic
lectures, supervised outpatient and inpatient clinical
experience, and the opportunity to do electives at other
sites. Internal Medicine Residents from the Department of Medicine
rotate through the clinical program, as well as College of Human Medicine Medical Students, College of Osteopathic Medicine Medical Students and undergrads from the REPID Program.
Clinical: 517-975-9500 or http://www.healthteam.msu.edu/ClinicDetails.aspx?ID=MSUBCC